WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2018”
Non-ulcer dyspepsia is a term used to describe signs and symptoms of indigestion that have no obvious cause. Non-ulcer dyspepsia is also called functional dyspepsia or non-ulcer stomach pain. Signs and symptoms include burning sensation or discomfort in upper abdomen or lower chest, sometimes relieved by food or antacids, bloating, belching and nausea.
The predisposing factors include consuming excessive amounts of caffeine or alcohol, smoking and taking certain medications, especially certain over-the-counter pain relievers, such as aspirin and ibuprofen (advil, motrin, others), which can cause stomach problems. Treatment includes medications to reduce acid production, antibiotics and low-dose antidepressants.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811465-functional-non-ulcer-dyspepsia-pipeline-review-h1-2018
Functional (Non Ulcer) Dyspepsia Industry Major Highlights:
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Functional (Non Ulcer) Dyspepsia (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Functional (Non Ulcer) Dyspepsia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 1, 2 and 1 respectively. Similarly, the Universities portfolio in Discovery stages comprises 1 molecules, respectively.
Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Major Outlook for Functional (Non Ulcer) Dyspepsia Report:
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Functional (Non Ulcer) Dyspepsia therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Functional (Non Ulcer) Dyspepsia therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Functional (Non Ulcer) Dyspepsia
The pipeline guide provides a snapshot of the global therapeutic landscape of Functional (Non Ulcer) Dyspepsia.
- The pipeline guide reviews pipeline therapeutics for Functional (Non Ulcer) Dyspepsia by companies and universities/research institutes based on information derived from company and industry-specific sources.
Competitive Analysis for Functional (Non Ulcer) Dyspepsia
Key players are making innovative developments in Functional (Non Ulcer) Dyspepsia industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector.
The key players in this market are Daewoong Pharmaceutical Co Ltd, RaQualia Pharma Inc, and Zeria Pharmaceutical Co Ltd.
Table of Contents
Global Markets Direct Report Coverage 5
Functional (Non Ulcer) Dyspepsia - Overview 6
Functional (Non Ulcer) Dyspepsia - Therapeutics Development 7
Pipeline Overview 7
Pipeline by Companies 8
Products under Development by Companies 10
Functional (Non Ulcer) Dyspepsia - Therapeutics Assessment 11
Assessment by Target 11
Assessment by Mechanism of Action 13
Assessment by Route of Administration 15
Assessment by Molecule Type 17
Functional (Non Ulcer) Dyspepsia - Companies Involved in Therapeutics Development 19
ActiveSite Pharmaceuticals Inc 19
Coherus BioSciences Inc 19
Lupin Ltd 20
Mabion SA 20
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2811465-functional-non-ulcer-dyspepsia-pipeline-review-h1-2018
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
P: +44 208 133 9349
M: +1 646 845 9349